Summary of clinical data for B-CLL patient samples, n = 11
| Donor no. . | Sex, age, y . | Rai stage . | Leukocyte/lymphocyte counts, ×109/L . | %CD5/CD19† . | %CD40† . |
|---|---|---|---|---|---|
| C4 | M, 43 | 2 | NA | 71 | 92 |
| C21 | M, 72 | 2 | NA | 53 | 78 |
| C22 | M, 59 | 4 | 77.8 | 88 | 86 |
| C27 | F, 54 | 2 | 98 | 83 | 90 |
| C30 | F, 41 | 2 | 150 | 80 | 84 |
| C31 | M, 43 | 2 | 30.1 | 84 | 85 |
| C32 | M, 45 | 2 | 31 | 88 | 84 |
| C33 | F, 58 | 0 | 34.4 | 66 | 76 |
| M9 | M, 50 | 1 | 73.7* | 88 | 92 |
| M10 | M, 76 | 0 | 38.2* | 90 | 92 |
| M11 | M, 64 | 4 | 39.2* | 86 | 93 |
| Donor no. . | Sex, age, y . | Rai stage . | Leukocyte/lymphocyte counts, ×109/L . | %CD5/CD19† . | %CD40† . |
|---|---|---|---|---|---|
| C4 | M, 43 | 2 | NA | 71 | 92 |
| C21 | M, 72 | 2 | NA | 53 | 78 |
| C22 | M, 59 | 4 | 77.8 | 88 | 86 |
| C27 | F, 54 | 2 | 98 | 83 | 90 |
| C30 | F, 41 | 2 | 150 | 80 | 84 |
| C31 | M, 43 | 2 | 30.1 | 84 | 85 |
| C32 | M, 45 | 2 | 31 | 88 | 84 |
| C33 | F, 58 | 0 | 34.4 | 66 | 76 |
| M9 | M, 50 | 1 | 73.7* | 88 | 92 |
| M10 | M, 76 | 0 | 38.2* | 90 | 92 |
| M11 | M, 64 | 4 | 39.2* | 86 | 93 |